Intrinsic Therapeutics, a Woburn-based medical device company, has raised $11.7 million in a round of venture capital, according to a new filing by the company with the Securities and Exchange Commission. Eleven separate investors participated in the offering.

Intrinsic Therapeutics is a medical device company focused on developing innovative therapies that address the spine market's many unmet clinical needs. The company's first product, Barricaid, is a revolutionary spinal implant that was developed to treat patients undergoing surgery for herniated lumbar discs.